RAPPRapport Therapeutics, Inc.
- Market cap
- $1.24B
- as of 2026-10-23
- Latest close
- $25.93
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
6 insiders bought $1.66M between Oct 21 – Oct 23.
Under the default rule (14d · ≥2 insiders · all roles).
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | Holding change | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Ignelzi Troy A.Chief Financial Officer | Oct 21 | Oct 21 | P | 5,500 | $26.10 | Purchase +$143,550 | 15,500 | +55.0% | No | Form 4 |
| Silva Paul M | Oct 22 | Oct 22 | P | 3,680 | $27.08 | Purchase +$99,636 | 3,680 | not reported | No | Form 4 |
| Young Wendy B. | Oct 22 | Oct 22 | P | 3,789 | $26.39 | Purchase +$99,992 | 13,289 | +39.9% | No | Form 4 |
| Paul Steven M | Oct 22 | Oct 22 | P | 35,714 | $27.28 | Purchase +$974,278 | 77,380 | +85.7% | No | Form 4 |
| Maraganore John | Oct 22 | Oct 22 | P | 8,239 | $26.38 | Purchase +$217,344 | 8,239 | not reported | No | Form 4 |
| Maraganore John | Oct 22 | Oct 22 | P | 1,172 | $26.92 | Purchase +$31,547 | 9,411 | +14.2% | No | Form 4 |
| Sanchez Ramiro | Oct 23 | Oct 23 | P | 3,600 | $27.35 | Purchase +$98,478 | 3,600 | not reported | No | Form 4 |
Form 4 historysince 2024-06-10
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sanchez Ramiro | Oct 23 | Oct 23 | P | 3,600 | $27.35 | Purchase +$98,478 | 3,600 | No | Form 4 |
| Ceesay AbrahamChief Executive Officer | Oct 21 | Oct 23 | S | 2,210 | $29.16 | Sale −$64,448 | 450,035 | Yes | Form 4 |
| Silva Paul M | Oct 22 | Oct 22 | P | 3,680 | $27.08 | Purchase +$99,636 | 3,680 | No | Form 4 |
| Young Wendy B. | Oct 22 | Oct 22 | P | 3,789 | $26.39 | Purchase +$99,992 | 13,289 | No | Form 4 |
| Paul Steven M | Oct 22 | Oct 22 | P | 35,714 | $27.28 | Purchase +$974,278 | 77,380 | No | Form 4 |
| Maraganore John | Oct 22 | Oct 22 | P | 8,239 | $26.38 | Purchase +$217,344 | 8,239 | No | Form 4 |
| Maraganore John | Oct 22 | Oct 22 | P | 1,172 | $26.92 | Purchase +$31,547 | 9,411 | No | Form 4 |
| Ignelzi Troy A.Chief Financial Officer | Oct 21 | Oct 21 | P | 5,500 | $26.10 | Purchase +$143,550 | 15,500 | No | Form 4 |
| Ceesay AbrahamChief Executive Officer | Oct 7 | Oct 8 | S | 1,147 | $30.66 | Sale −$35,167 | 452,245 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Oct 6 | Oct 8 | S | 3,375 | $32.03 | Sale −$108,106 | 453,392 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Sep 30 | Oct 1 | S | 7,925 | $33.04 | Sale −$261,813 | 141,989 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Sep 30 | Oct 1 | S | 2,075 | $33.76 | Sale −$70,043 | 139,914 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 23 | Sep 24 | S | 1,952 | $39.05 | Sale −$76,226 | 457,025 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 23 | Sep 24 | S | 215 | $39.86 | Sale −$8,570 | 456,810 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 23 | Sep 24 | S | 43 | $41.05 | Sale −$1,765 | 456,767 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 8 | Sep 9 | S | 7,141 | $45.56 | Sale −$325,344 | 460,046 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 8 | Sep 9 | S | 1,069 | $46.01 | Sale −$49,185 | 458,977 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Aug 25 | Aug 26 | S | 20,799 | $50.31 | Sale −$1,046,398 | 212,063 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Aug 25 | Aug 26 | S | 16,201 | $51.06 | Sale −$827,223 | 195,862 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Aug 25 | Aug 26 | S | 18,921 | $49.57 | Sale −$937,914 | 467,187 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Aug 24 | Aug 26 | S | 13,160 | $50.00 | Sale −$658,000 | 232,862 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Aug 19 | Aug 20 | S | 404 | $49.90 | Sale −$20,160 | 246,022 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Aug 11 | Aug 12 | S | 3,664 | $46.90 | Sale −$171,842 | 511,402 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Aug 11 | Aug 12 | S | 19,500 | $48.04 | Sale −$936,780 | 491,902 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Aug 11 | Aug 12 | S | 5,794 | $48.62 | Sale −$281,704 | 486,108 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Aug 10 | Aug 12 | S | 14,171 | $45.97 | Sale −$651,441 | 523,436 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Aug 10 | Aug 12 | S | 8,370 | $46.75 | Sale −$391,298 | 515,066 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jul 27 | Jul 29 | S | 2,203 | $42.11 | Sale −$92,768 | 537,614 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jul 27 | Jul 29 | S | 7 | $42.74 | Sale −$299 | 537,607 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jul 14 | Jul 15 | S | 5,481 | $39.72 | Sale −$217,705 | 542,546 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jul 14 | Jul 15 | S | 2,729 | $40.57 | Sale −$110,716 | 539,817 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Jun 30 | Jul 1 | S | 1,900 | $40.09 | Sale −$76,171 | 158,014 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Jun 30 | Jul 1 | S | 3,792 | $41.39 | Sale −$156,951 | 154,222 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Jun 30 | Jul 1 | S | 3,308 | $42.17 | Sale −$139,498 | 150,914 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Jun 30 | Jul 1 | S | 1,000 | $43.15 | Sale −$43,150 | 149,914 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jun 29 | Jul 1 | S | 7,344 | $39.77 | Sale −$292,071 | 548,903 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jun 29 | Jul 1 | S | 876 | $40.34 | Sale −$35,338 | 548,027 | Yes | Form 4 |
| Sanchez Ramiro | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Young Wendy B. | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Huber Reid M | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Healy James | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Silva Paul M | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Paul Steven M | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Perez Robert J | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Maraganore John | Jun 10 | Jun 10 | A · derivative | 15,200 | $35.21 | $535,192 | 15,200 | No | Form 4 |
| Third Rock Ventures V, L.P. | May 26 | May 28 | S | 18,572 | $40.05 | Sale −$743,809 | 6,280,525 | Yes | Form 4 |
| Third Rock Ventures V, L.P. | May 11 | May 13 | S | 133,618 | $40.24 | Sale −$5,376,788 | 6,299,097 | Yes | Form 4 |
| Third Rock Ventures VI, L.P. | May 8 | May 11 | S | 5,018 | $40.31 | Sale −$202,276 | 6,432,715 | Yes | Form 4 |
| Third Rock Ventures VI, L.P. | May 7 | May 11 | S | 271,495 | $40.12 | Sale −$10,892,379 | 6,437,733 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Apr 17 | Apr 21 | S | 20,225 | $39.99 | Sale −$808,798 | 246,426 | Yes | Form 4 |
| Third Rock Ventures VI, L.P. | Apr 17 | Apr 21 | S | 426,005 | $40.32 | Sale −$17,176,522 | 6,709,228 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Apr 14 | Apr 14 | S | 10,200 | $35.08 | Sale −$357,816 | 266,651 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Apr 13 | Apr 14 | S | 9,165 | $34.97 | Sale −$320,500 | 276,851 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Apr 10 | Apr 14 | S | 500 | $34.98 | Sale −$17,490 | 286,016 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Apr 8 | Apr 9 | S | 360 | $34.90 | Sale −$12,564 | 286,516 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Mar 30 | Mar 31 | S | 7,161 | $28.04 | Sale −$200,794 | 162,753 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Mar 30 | Mar 31 | S | 2,839 | $28.55 | Sale −$81,053 | 159,914 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Mar 25 | Mar 26 | S | 10,115 | $29.99 | Sale −$303,349 | 286,876 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Mar 5 | Mar 9 | S | 2,014 | $28.93 | Sale −$58,265 | 169,914 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Feb 19 | Feb 19 | M | 6,000 | $1.80 | $10,800 | 393,075 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Feb 19 | Feb 19 | M · derivative | 6,000 | $1.80 | $10,800 | 88,080 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Feb 18 | Feb 19 | S | 3,552 | $29.05 | Sale −$103,186 | 558,528 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Feb 18 | Feb 19 | S | 2,281 | $29.80 | Sale −$67,974 | 556,247 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Feb 18 | Feb 19 | S | 2,983 | $29.04 | Sale −$86,626 | 22,829 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Feb 18 | Feb 19 | S | 2,100 | $29.80 | Sale −$62,580 | 20,729 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Feb 17 | Feb 19 | S | 900 | $28.02 | Sale −$25,218 | 394,675 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Feb 17 | Feb 19 | S | 5,400 | $28.95 | Sale −$156,330 | 389,275 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Feb 17 | Feb 19 | S | 2,200 | $29.59 | Sale −$65,098 | 387,075 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Feb 2 | Feb 4 | A · derivative | 132,000 | $27.75 | $3,663,000 | 132,000 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Feb 2 | Feb 4 | A · derivative | 103,000 | $27.75 | $2,858,250 | 103,000 | No | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Feb 2 | Feb 4 | A · derivative | 120,000 | $27.75 | $3,330,000 | 120,000 | No | Form 4 |
| Ignelzi Troy A.Chief Financial Officer | Feb 2 | Feb 4 | A · derivative | 148,000 | $27.75 | $4,107,000 | 148,000 | No | Form 4 |
| Ceesay AbrahamChief Executive Officer | Feb 2 | Feb 4 | A · derivative | 428,000 | $27.75 | $11,877,000 | 428,000 | No | Form 4 |
| Sevigny JeffreyChief Medical Officer | Feb 2 | Feb 4 | A · derivative | 130,000 | $27.75 | $3,607,500 | 130,000 | No | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jan 20 | Jan 22 | S | 5,833 | $26.12 | Sale −$152,358 | 562,080 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jan 20 | Jan 22 | S | 5,083 | $26.11 | Sale −$132,717 | 25,812 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Jan 15 | Jan 16 | S | 8,300 | $26.83 | Sale −$222,689 | 395,775 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Jan 15 | Jan 16 | S | 200 | $27.40 | Sale −$5,480 | 395,575 | Yes | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Dec 31, 2025 | Jan 5 | A | 9,000 | not reported | not reported | 299,831 | No | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Dec 31, 2025 | Jan 5 | S | 2,840 | $30.05 | Sale −$85,342 | 296,991 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Dec 31, 2025 | Jan 5 | A | 18,000 | not reported | not reported | 410,642 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Dec 31, 2025 | Jan 5 | S | 6,567 | $30.05 | Sale −$197,338 | 404,075 | No | Form 4 |
| Ceesay AbrahamChief Executive Officer | Dec 17, 2025 | Dec 18, 2025 | S | 2,441 | $28.84 | Sale −$70,398 | 571,305 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Dec 17, 2025 | Dec 18, 2025 | S | 2,792 | $30.04 | Sale −$83,872 | 568,513 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Dec 17, 2025 | Dec 18, 2025 | S | 600 | $31.04 | Sale −$18,624 | 567,913 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Dec 17, 2025 | Dec 18, 2025 | S | 2,147 | $28.84 | Sale −$61,919 | 33,831 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Dec 17, 2025 | Dec 18, 2025 | S | 2,421 | $30.04 | Sale −$72,727 | 31,410 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Dec 17, 2025 | Dec 18, 2025 | S | 515 | $31.04 | Sale −$15,986 | 30,895 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Dec 15, 2025 | Dec 16, 2025 | S | 7,704 | $29.95 | Sale −$230,735 | 393,438 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Dec 15, 2025 | Dec 16, 2025 | S | 796 | $30.68 | Sale −$24,421 | 392,642 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Nov 26, 2025 | Dec 1, 2025 | M | 5,000 | $1.80 | $9,000 | 176,928 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Nov 26, 2025 | Dec 1, 2025 | S | 5,000 | $30.10 | Sale −$150,500 | 171,928 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Nov 26, 2025 | Dec 1, 2025 | M · derivative | 5,000 | $1.80 | $9,000 | 105,407 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Nov 17, 2025 | Nov 18, 2025 | S | 3,156 | $24.84 | Sale −$78,395 | 406,486 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Nov 17, 2025 | Nov 18, 2025 | S | 5,344 | $25.39 | Sale −$135,684 | 401,142 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Nov 17, 2025 | Nov 18, 2025 | S | 2,777 | $24.92 | Sale −$69,203 | 576,802 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Nov 17, 2025 | Nov 18, 2025 | S | 3,056 | $25.43 | Sale −$77,714 | 573,746 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Nov 17, 2025 | Nov 18, 2025 | S | 2,242 | $24.91 | Sale −$55,848 | 38,819 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Nov 17, 2025 | Nov 18, 2025 | S | 2,841 | $25.44 | Sale −$72,275 | 35,978 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Oct 15, 2025 | Oct 16, 2025 | S | 4,647 | $25.72 | Sale −$119,521 | 580,765 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Oct 15, 2025 | Oct 16, 2025 | S | 1,186 | $26.14 | Sale −$31,002 | 579,579 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Oct 15, 2025 | Oct 16, 2025 | S | 4,328 | $25.75 | Sale −$111,446 | 41,816 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Oct 15, 2025 | Oct 16, 2025 | S | 755 | $26.17 | Sale −$19,758 | 41,061 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Oct 15, 2025 | Oct 16, 2025 | S | 7,418 | $25.73 | Sale −$190,865 | 410,724 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Oct 15, 2025 | Oct 16, 2025 | S | 1,082 | $26.16 | Sale −$28,305 | 409,642 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 17, 2025 | Sep 19, 2025 | S | 39,435 | $26.30 | Sale −$1,037,141 | 586,812 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 17, 2025 | Sep 19, 2025 | S | 1,400 | $26.87 | Sale −$37,618 | 585,412 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 17, 2025 | Sep 19, 2025 | S | 34,885 | $26.30 | Sale −$917,476 | 46,844 | Yes | Form 4 |
| Ceesay AbrahamChief Executive Officer | Sep 17, 2025 | Sep 19, 2025 | S | 700 | $27.04 | Sale −$18,928 | 46,144 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Sep 15, 2025 | Sep 17, 2025 | S | 5,098 | $23.88 | Sale −$121,740 | 421,544 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Sep 15, 2025 | Sep 17, 2025 | S | 3,402 | $24.66 | Sale −$83,893 | 418,142 | Yes | Form 4 |
| Paul Steven M | Sep 12, 2025 | Sep 15, 2025 | P | 28,284 | $24.50 | Purchase +$692,958 | 28,284 | No | Form 4 |
| Paul Steven M | Sep 12, 2025 | Sep 15, 2025 | P | 13,382 | $24.97 | Purchase +$334,149 | 41,666 | No | Form 4 |
| Huber Reid M | Sep 12, 2025 | Sep 15, 2025 | P | 20,400 | $24.48 | Purchase +$499,392 | 20,400 | No | Form 4 |
| Young Wendy B. | Sep 11, 2025 | Sep 11, 2025 | P | 3,500 | $22.60 | Purchase +$79,100 | 9,500 | No | Form 4 |
| Gault CherylChief Operating Officer | Sep 8, 2025 | Sep 10, 2025 | M | 5,000 | $1.80 | $9,000 | 176,928 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Sep 8, 2025 | Sep 10, 2025 | S | 5,000 | $38.33 | Sale −$191,650 | 171,928 | Yes | Form 4 |
| Gault CherylChief Operating Officer | Sep 8, 2025 | Sep 10, 2025 | M · derivative | 5,000 | $1.80 | $9,000 | 110,407 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Aug 15, 2025 | Aug 18, 2025 | S | 8,300 | $14.98 | Sale −$124,334 | 426,842 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Aug 15, 2025 | Aug 18, 2025 | S | 200 | $15.79 | Sale −$3,158 | 426,642 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Jul 15, 2025 | Jul 16, 2025 | S | 8,500 | $14.00 | Sale −$119,000 | 435,142 | Yes | Form 4 |
| Silva Paul M | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 10,925 | $10.95 | $119,629 | 10,925 | No | Form 4 |
| Paul Steven M | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 21,850 | $10.95 | $239,258 | 21,850 | No | Form 4 |
| Huber Reid M | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 21,850 | $10.95 | $239,258 | 21,850 | No | Form 4 |
| Perez Robert J | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 10,925 | $10.95 | $119,629 | 10,925 | No | Form 4 |
| Healy James | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 21,850 | $10.95 | $239,258 | 21,850 | No | Form 4 |
| Maraganore John | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 21,850 | $10.95 | $239,258 | 21,850 | No | Form 4 |
| Young Wendy B. | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 10,925 | $10.95 | $119,629 | 10,925 | No | Form 4 |
| Sanchez Ramiro | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 10,925 | $10.95 | $119,629 | 10,925 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Jun 16, 2025 | Jun 18, 2025 | S | 8,500 | $11.00 | Sale −$93,500 | 443,642 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | May 15, 2025 | May 19, 2025 | S | 8,500 | $9.56 | Sale −$81,260 | 452,142 | Yes | Form 4 |
| Bredt DavidChief Scientific Officer | Apr 15, 2025 | Apr 16, 2025 | S | 8,500 | $9.57 | Sale −$81,345 | 460,642 | Yes | Form 4 |
| Sevigny JeffreyChief Medical Officer | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 300,000 | $9.56 | $2,868,000 | 300,000 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Mar 14, 2025 | Mar 17, 2025 | S | 8,500 | $10.85 | Sale −$92,225 | 469,142 | Yes | Form 4 |
| Ignelzi Troy A.Chief Financial Officer | Mar 13, 2025 | Mar 13, 2025 | P | 100 | $9.98 | Purchase +$998 | 10,000 | No | Form 4 |
| Young Wendy B. | Mar 12, 2025 | Mar 13, 2025 | P | 6,000 | $10.21 | Purchase +$61,260 | 6,000 | No | Form 4 |
| Ignelzi Troy A.Chief Financial Officer | Mar 12, 2025 | Mar 13, 2025 | P | 9,900 | $10.10 | Purchase +$99,990 | 9,900 | No | Form 4 |
| Gault CherylChief Operating Officer | Mar 3, 2025 | Mar 5, 2025 | A | 13,987 | $0.00 | $0 | 171,928 | No | Form 4 |
| Gault CherylChief Operating Officer | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 129,000 | $16.60 | $2,141,400 | 129,000 | No | Form 4 |
| Ceesay AbrahamChief Executive Officer | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 428,000 | $16.60 | $7,104,800 | 428,000 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 100,000 | $16.60 | $1,660,000 | 100,000 | No | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 110,000 | $16.60 | $1,826,000 | 110,000 | No | Form 4 |
| Ignelzi Troy A.Chief Financial Officer | Feb 3, 2025 | Feb 4, 2025 | A · derivative | 142,000 | $16.60 | $2,357,200 | 142,000 | No | Form 4 |
| Sanchez Ramiro | Nov 7, 2024 | Nov 7, 2024 | A · derivative | 29,756 | $26.90 | $800,436 | 29,756 | No | Form 4 |
| Silva Paul M | Nov 7, 2024 | Nov 7, 2024 | A · derivative | 29,756 | $26.90 | $800,436 | 29,756 | No | Form 4 |
| Perez Robert J | Nov 7, 2024 | Nov 7, 2024 | A · derivative | 29,756 | $26.90 | $800,436 | 29,756 | No | Form 4 |
| Young Wendy B. | Nov 7, 2024 | Nov 7, 2024 | A · derivative | 29,756 | $26.90 | $800,436 | 29,756 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 3,538 | $23.08 | Purchase +$81,657 | 28,993 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 3,565 | $24.21 | Purchase +$86,309 | 32,558 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 4,544 | $25.02 | Purchase +$113,691 | 37,102 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 2,559 | $26.06 | Purchase +$66,688 | 39,661 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 3,799 | $23.08 | Purchase +$87,681 | 21,660 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 3,828 | $24.21 | Purchase +$92,676 | 25,488 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 4,878 | $25.02 | Purchase +$122,048 | 30,366 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 2,748 | $26.06 | Purchase +$71,613 | 33,114 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 3,630 | $23.08 | Purchase +$83,780 | 29,908 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 3,657 | $24.21 | Purchase +$88,536 | 33,565 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 4,661 | $25.02 | Purchase +$116,618 | 38,226 | No | Form 4 |
| Healy James | Jul 1, 2024 | Jul 3, 2024 | P | 2,625 | $26.06 | Purchase +$68,408 | 40,851 | No | Form 4 |
| Healy James | Jun 10, 2024 | Jun 10, 2024 | C | 1,392,738 | $0.00 | $0 | 1,392,738 | No | Form 4 |
| Healy James | Jun 10, 2024 | Jun 10, 2024 | P | 470,589 | $17.00 | Purchase +$8,000,013 | 1,863,327 | No | Form 4 |
| Healy James | Jun 10, 2024 | Jun 10, 2024 | P | 18,641 | $17.00 | Purchase +$316,897 | 18,641 | No | Form 4 |
| Healy James | Jun 10, 2024 | Jun 10, 2024 | P | 17,861 | $17.00 | Purchase +$303,637 | 17,861 | No | Form 4 |
| Healy James | Jun 10, 2024 | Jun 10, 2024 | P | 26,278 | $17.00 | Purchase +$446,726 | 26,278 | No | Form 4 |
| Healy James | Jun 10, 2024 | Jun 10, 2024 | P | 25,455 | $17.00 | Purchase +$432,735 | 25,455 | No | Form 4 |
| Healy James | Jun 10, 2024 | Jun 10, 2024 | C · derivative | 11,924,138 | $0.00 | $0 | not reported | No | Form 4 |
| Third Rock Ventures V, L.P. | Jun 10, 2024 | Jun 10, 2024 | C | 6,551,449 | $0.00 | $0 | 7,135,233 | No | Form 4 |
| Third Rock Ventures V, L.P. | Jun 10, 2024 | Jun 10, 2024 | C | 969,218 | $0.00 | $0 | 969,218 | No | Form 4 |
| Third Rock Ventures V, L.P. | Jun 10, 2024 | Jun 10, 2024 | C · derivative | 56,091,177 | $0.00 | $0 | not reported | No | Form 4 |
| Third Rock Ventures V, L.P. | Jun 10, 2024 | Jun 10, 2024 | C · derivative | 8,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Third Rock Ventures V, L.P. | Jun 10, 2024 | Jun 10, 2024 | C · derivative | 298,103 | $0.00 | $0 | not reported | No | Form 4 |
| Nelsen Robert | Jun 10, 2024 | Jun 10, 2024 | C | 3,728,738 | $0.00 | $0 | 3,728,738 | No | Form 4 |
| Nelsen Robert | Jun 10, 2024 | Jun 10, 2024 | C · derivative | 20,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Nelsen Robert | Jun 10, 2024 | Jun 10, 2024 | C · derivative | 11,924,138 | $0.00 | $0 | not reported | No | Form 4 |
| Ignelzi Troy A.Chief Financial Officer | Jun 6, 2024 | Jun 10, 2024 | A · derivative | 81,366 | $17.00 | $1,383,222 | 81,366 | No | Form 4 |
| Ceesay AbrahamChief Executive Officer | Jun 6, 2024 | Jun 10, 2024 | A · derivative | 530,647 | $17.00 | $9,020,999 | 530,647 | No | Form 4 |
| Yeleswaram KrishnaswamyChief Development Officer | Jun 6, 2024 | Jun 10, 2024 | A · derivative | 84,904 | $17.00 | $1,443,368 | 84,904 | No | Form 4 |
| Bredt DavidChief Scientific Officer | Jun 6, 2024 | Jun 10, 2024 | A · derivative | 28,302 | $17.00 | $481,134 | 28,302 | No | Form 4 |
| Gault CherylChief Operations Officer | Jun 6, 2024 | Jun 10, 2024 | A · derivative | 88,442 | $17.00 | $1,503,514 | 88,442 | No | Form 4 |
| Galer Bradley S.Chief Medical Officer | Jun 6, 2024 | Jun 10, 2024 | A · derivative | 123,818 | $17.00 | $2,104,906 | 123,818 | No | Form 4 |